Metastatic Ocular Melanoma
4 clinical trials · Condition
◉ Watch Metastatic Ocular Melanoma
| Record | Firm | Date |
|---|---|---|
| An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma (NCT05022901) | Delcath Systems Inc. | 2022-06-10 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma (NCT01814046) | National Cancer Institute (NCI) | 2013-03-01 |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661) | Provectus Biopharmaceuticals, Inc. | 2009-10-01 |
Track Metastatic Ocular Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.